RELIEF THERAPEUTICS announces the results of its annual general meeting of shareholders, which took place in Geneva. All but one of the proposed resolutions were approved by a large majority of the represented votes. The AGM did not grant discharge to the board of directors and the executive committee for the financial year 2023. While the extraordinary general meeting earlier this year granted such discharge for that period, the Company acknowledges this outcome and will continue to engage with shareholders to address their concerns